公开(公告)号：US20220119411A1

公开(公告)日：2022-04-21

申请号：US17259187

申请日：2019-07-12

Applicant: BETTA PHARMACEUTICALS CO., LTD

Inventor： Bang FU ,  Yao ZHANG ,  Yiqian WANG ,  Xiangyong LIU ,  Jiabing WANG ,  Lieming DING

IPC: C07D513/04 ,  C07D471/04 ,  C07D498/04 ,  C07D519/00 ,  C07D487/04 ,  C07D417/14

Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.

公开(公告)号：US20220098183A1

公开(公告)日：2022-03-31

申请号：US17427112

申请日：2020-01-20

Applicant: Betta Pharmaceuticals Co.,Ltd

Inventor： Yiqian WANG ,  Yao ZHANG ,  Bang FU ,  Jiabing WANG ,  Lieming DING

IPC: C07D413/14 ,  C07D487/04 ,  C07D471/10 ,  C07D495/10 ,  C07D487/08 ,  C07D451/02 ,  C07D491/107 ,  C07D498/04

Abstract: Provided herein are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.

公开(公告)号：US20210300909A1

公开(公告)日：2021-09-30

申请号：US17261013

申请日：2019-07-19

Applicant: BETTA PHARMACEUTICALS CO., LTD

Inventor： Yiqian WANG ,  Yao ZHANG ,  Bang FU ,  Jiabing WANG ,  Lieming DING

IPC: C07D413/06 ,  C07D263/57 ,  C07D401/04 ,  C07D401/06 ,  C07D413/14 ,  C07D417/06 ,  C07D277/66

Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.

公开(公告)号：US20210269440A1

公开(公告)日：2021-09-02

申请号：US17260547

申请日：2019-07-19

Applicant: BETTA PHARMACEUTICALS CO., LTD

Inventor： Yao ZHANG ,  Yiqian WANG ,  Bang FU ,  Jie CHEN ,  Jiabing WANG ,  Lieming DING

IPC: C07D471/04

Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.

公开(公告)号：US20210040118A1

公开(公告)日：2021-02-11

申请号：US17041455

申请日：2019-04-03

Applicant: BETTA PHARMACEUTICALS CO., LTD

Inventor： Yiqian WANG ,  Bang FU ,  Yao ZHANG ,  Xiangyong LIU ,  Jiabing WANG ,  Lieming DING

IPC: C07D513/04 ,  C07D417/14 ,  C07D495/04 ,  C07D471/04 ,  C07D277/56 ,  C07D487/04 ,  C07D271/10 ,  C07D519/00 ,  C07D498/04 ,  C07D285/12

Abstract: The present invention relates to compounds of Formula I, methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.